Self-promotion and online shaming during COVID-19: A toxic combination

Behera, Rajat Kumar; Bala, Pradip Kumar; Rana, Nripendra P.; Kayal, Ghadeer

doi:10.1016/j.jjimei.2022.100117

Cited by 7 publications

(4 citation statements)

References 157 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The matched-pairs technique is a moderation test that makes use of latent constructs in a structural model and uses a condensed interaction term rather than modelling every potential indicator interaction. To minimise problems that typically occur while analysing measurement instruments with lots of items, the highest loading factor indicators were chosen where no indicator repeatedly occurred (Behera et al. , 2022).…”

Section: Resultsmentioning

confidence: 99%

Assessing factors influencing consumers' non-adoption intention: exploring the dark sides of mobile payment

Behera

Bala

Rana

2022

ITP

View full text Add to dashboard Cite

PurposeThe new ways to complete financial transactions have been developed by setting up mobile payment (m-payment) platforms and such platforms to access banking in the financial mainstream can transact as never before. But, does m-payment have veiled consequences? To seek an answer, the research was undertaken to explore the dark sides of m-payment for consumers by extending the theory of innovation resistance (IR) and by measuring non-adoption intention (NAI).Design/methodology/approachThree hundred individuals using popular online m-payment apps such as Paytm, PhonePe, Amazon Pay and Google Pay were surveyed for the primary data. IBM AMOS based structural equation modelling (SEM) was used to analyse the data.FindingsEach m-payment transaction leaves a digital record, making some vulnerable consumers concerned about privacy threats. Lack of global standards prevents consumers from participating in the m-payment system properly until common interfaces are established based on up-to-date standards. Self-compassion (SC) characteristics such as anxiety, efficacy, fatigue, wait-and-see tendencies and the excessive choice of technology effect contribute to the non-adoption of m-payment.Originality/valueThis study proposes a threat model and empirically explores the dark sides of m-payment. In addition, it also unveils the moderator's role of SC in building the structural relationship between IR and NAI.

show abstract

Section: Resultsmentioning

confidence: 99%

Assessing factors influencing consumers' non-adoption intention: exploring the dark sides of mobile payment

Behera

Bala

Rana

2022

ITP

View full text Add to dashboard Cite

show abstract

“…Another is for educational institutions to switch to digital learning modalities and for enterprises to implement self-isolation/work from home programmes [38]. According to modelling projections, integrated NPIs are anticipated to have the biggest and fastest impact on reducing the reproductive number and slowing the rate of viral transmission if they are adopted early in the outbreak [199,202,203]. The creation of efficient treatment interventions and vaccines is made possible using the knowledge gained from these NPIs, which are interim measures while the effort to better understand viral genomes continues [38,201].…”

Section: Non-pharmacological Interventionsmentioning

confidence: 99%

Unravelling Insights into the Evolution and Management of SARS-CoV-2

Mushebenge,

Ugbaja,

Mbatha

et al. 2024

BioMedInformatics

View full text Add to dashboard Cite

Worldwide, the COVID-19 pandemic, caused by the brand-new coronavirus SARS-CoV-2, has claimed a sizable number of lives. The virus’ rapid spread and impact on every facet of human existence necessitate a continuous and dynamic examination of its biology and management. Despite this urgency, COVID-19 does not currently have any particular antiviral treatments. As a result, scientists are concentrating on repurposing existing antiviral medications or creating brand-new ones. This comprehensive review seeks to provide an in-depth exploration of our current understanding of SARS-CoV-2, starting with an analysis of its prevalence, pathology, and evolutionary trends. In doing so, the review aims to clarify the complex network of factors that have contributed to the varying case fatality rates observed in different geographic areas. In this work, we explore the complex world of SARS-CoV-2 mutations and their implications for vaccine efficacy and therapeutic interventions. The dynamic viral landscape of the pandemic poses a significant challenge, leading scientists to investigate the genetic foundations of the virus and the mechanisms underlying these genetic alterations. Numerous hypotheses have been proposed as the pandemic has developed, covering various subjects like the selection pressures driving mutation, the possibility of vaccine escape, and the consequences for clinical therapy. Furthermore, this review will shed light on current clinical trials investigating novel medicines and vaccine development, including the promising field of drug repurposing, providing a window into the changing field of treatment approaches. This study provides a comprehensive understanding of the virus by compiling the huge and evolving body of knowledge on SARS-CoV-2, highlighting its complexities and implications for public health, and igniting additional investigation into the control of this unprecedented global health disaster.

show abstract

“…Travel restrictions, social withdrawal, enhanced hygiene, and consistent hand washing can also help stop the virus's spread. Schools may need to switch to digital learning, and non-essential public areas and services may need to be shut down in order to execute these measures (110). Work from home efforts and self-isolation may also be required for enterprises.…”

Section: Non-pharmacological Interventionsmentioning

confidence: 99%

Unravelling Insights into the Evolution and Management of SARS-CoV-2: A Comprehensive Review

Mushebenge,

Ugbaja,

Mbatha

et al. 2023

Preprint

View full text Add to dashboard Cite

Worldwide, the COVID-19 pandemic, which was brought on by the brand-new coronavirus SARS-CoV-2, has claimed a sizable number of lives. Despite the urgency, COVID-19 does not have any particular antiviral treatments at this time. As a result, scientists are concentrating on repurposing already existing antiviral medications or creating brand-new ones. The SARS-CoV-2 main protease, which is necessary for viral replication, has been identified as a possible target for a family of medicines called main protease inhibitors (MPIs). Studies of the major proteases from SARS-CoV and MERS-CoV, which have remarkably similar structures and functions to SARS-CoV-2, have provided insight for the creation of MPIs. By analyzing the MPI trials for SARS-CoV and MERS-CoV, this review sheds light on the possible therapeutic uses of MPIs for COVID-19. The review talks about how MPIs work, how effective they are against SARS-CoV and MERS-CoV, and how safe they are. The paper also emphasizes current developments in the creation of MPIs for SARS-CoV-2, including as computational studies, in vitro and in vivo research, and clinical trials. According to the review, there is a lot of hope for MPIs in the treatment of COVID-19, and numerous medications are in the works. Although more research is needed to assess their safety and effectiveness in clinical settings, these medications may offer patients with COVID-19 a much-needed therapeutic option. The review also emphasizes the importance of ongoing research into the structure and function of the SARS-CoV-2 main protease, as this information will be critical for the development of effective MPIs and other antiviral drugs in the future.

show abstract

Self-promotion and online shaming during COVID-19: A toxic combination

Cited by 7 publications

References 157 publications

Assessing factors influencing consumers' non-adoption intention: exploring the dark sides of mobile payment

Assessing factors influencing consumers' non-adoption intention: exploring the dark sides of mobile payment

Unravelling Insights into the Evolution and Management of SARS-CoV-2

Unravelling Insights into the Evolution and Management of SARS-CoV-2: A Comprehensive Review

Contact Info

Product

Resources

About